Clinical Studies

Home / Clinical Studies

Strongest Brain’s ingredients are extensively clinically tested and documented on the U.S. National Institutes of Health database at https://clinicaltrials.gov

1. Ginkgo Biloba Extract

 

1.1 Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD (yuyu)

Sponsor:

Yuyu Pharma, Inc.

Information provided by:

Yuyu Pharma, Inc.

ClinicalTrials.gov Identifier:

NCT01201187

First received: September 12, 2010

Last updated: January 9, 2012

Last verified: September 2010

 

1.2 Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults
Sponsor:

Boehringer Ingelheim

Information provided by (Responsible Party):

Boehringer Ingelheim

ClinicalTrials.gov Identifier:

NCT02181972

First received: July 2, 2014

Last updated: July 17, 2014

Last verified: July 2014

 

1.3 Treatment for Early Memory Loss
Sponsor:

University of Iowa

Collaborator:

National Institute of Mental Health (NIMH)

Information provided by:

University of Iowa

ClinicalTrials.gov Identifier:

NCT00042172

First received: July 24, 2002

Last updated: February 27, 2014

Last verified: February 2014

2. Huperzine A

 

2.1 Huperzine A in Alzheimer’s Disease
Sponsor:

National Institute on Aging (NIA)

Collaborators:

Alzheimer’s Disease Cooperative Study (ADCS)

Neuro-Hitech

Information provided by:

National Institute on Aging (NIA)

ClinicalTrials.gov Identifier:

NCT00083590

First received: May 26, 2004

Last updated: February 19, 2008

Last verified: February 2008

 

2.2 Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Sponsor:

U.S. Army Medical Research and Materiel Command

Collaborator:

Walter Reed Army Institute of Research (WRAIR)

Information provided by (Responsible Party):

U.S. Army Medical Research and Materiel Command

ClinicalTrials.gov Identifier:

NCT01194336

First received: August 31, 2010

Last updated: November 27, 2012

Last verified: November 2012

 

2.3 Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players
Sponsor:

Amen Clinics, Inc.

Information provided by (Responsible Party):

Amen Clinics, Inc.

ClinicalTrials.gov Identifier:

NCT01515839

First received: October 1, 2010

Last updated: January 23, 2012

Last verified: January 2012

3. Rosemary Leaf Extract

 

3.1 Effects of Plant Concentrate Blend on Oxidative Stress in Healthy Humans
Sponsor:

Access Business Group

Information provided by (Responsible Party):

Access Business Group

ClinicalTrials.gov Identifier:

NCT02213588

First received: August 7, 2014

 

3.2 The DHA (Docosahexaenoic Acid) Oxford Learning and Behaviour (DOLAB) Study
Sponsor:

University of Oxford

Collaborator:

DSM Nutritional Products, Inc.

Information provided by:

University of Oxford

ClinicalTrials.gov Identifier:

NCT01066182

First received: February 9, 2010

Last updated: October 27, 2011

Last verified: February 2010

 

3.3 Diagnosis and Management of Inflammatory and Infectious Diseases
Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Information provided by (Responsible Party):

National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )

4. Gotu Kola

 

4.1 Effect of Bacopa Monniera Extract on Cognition and Anxiety and Exploration of PK Properties (Yaaddasht)

Sponsor:

Unilever R&D

Collaborator:

St. John’s Research Institute

Information provided by (Responsible Party):

Unilever R&D

ClinicalTrials.gov Identifier:

NCT02462642

First received: September 16, 2014

Last updated: June 1, 2015

Last verified: June 2015

 

4.2 Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children
Sponsor:

GlaxoSmithKline

Collaborator:

Cambridge Cognition

Information provided by (Responsible Party):

GlaxoSmithKline

ClinicalTrials.gov Identifier:

NCT02416245

First received: April 9, 2015

Last updated: July 2, 2015

Last verified: June 2015

5. Phosphatidyl Serine

 

5.1 Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD
Sponsor:

Tel-Aviv Sourasky Medical Center

Information provided by:

Tel-Aviv Sourasky Medical Center

ClinicalTrials.gov Identifier:

NCT00382616

First received: September 28, 2006

Last updated: November 6, 2006

Last verified: September 2006

 

5.2 Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy (AGPIn3)

Sponsor:

Hospices Civils de Lyon

Information provided by (Responsible Party):

Hospices Civils de Lyon

ClinicalTrials.gov Identifier:

NCT02348073

First received: January 22, 2015

Last updated: March 4, 2015

Last verified: January 2015

 

5.3 Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment

Sponsor:

Enzymotec

Information provided by (Responsible Party):

Enzymotec

ClinicalTrials.gov Identifier:

NCT02211560

First received: August 6, 2014

Last updated: November 13, 2014

Last verified: October 2014

6. L-Glutamine

 

6.1 Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients (REDOXS)
Sponsor:

Daren K. Heyland

Collaborator:

Fresenius Kabi

Information provided by (Responsible Party):

Daren K. Heyland, Clinical Evaluation Research Unit at Kingston General Hospital

ClinicalTrials.gov Identifier:

NCT00133978

First received: August 22, 2005

Last updated: August 26, 2014

Last verified: August 2014

 

6.2 Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients (REDOXS)
Sponsor:

Daren K. Heyland

Collaborator:

Fresenius Kabi

Information provided by (Responsible Party):

Daren K. Heyland, Clinical Evaluation Research Unit at Kingston General Hospital

ClinicalTrials.gov Identifier:

NCT00133978

First received: August 22, 2005

Last updated: August 26, 2014

Last verified: August 2014

 

6.3 Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
Sponsor:

Baylor College of Medicine

Collaborators:

National Alliance for Research on Schizophrenia and Depression

National Center for Research Resources (NCRR)

Information provided by (Responsible Party):

Sanjay Johan Mathew, Baylor College of Medicine

ClinicalTrials.gov Identifier:

NCT00419003

First received: January 4, 2007

Last updated: August 7, 2013

Last verified: August 2013

7. Choline

 

7.1 Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development
Sponsor:

University of Colorado, Denver

Information provided by (Responsible Party):

University of Colorado, Denver

ClinicalTrials.gov Identifier:

NCT00332124

First received: May 30, 2006

Last updated: May 29, 2015

Last verified: May 2015

 

7.2 Choline Nutrition in Children With Cystic Fibrosis (CF)

Sponsor:

University of British Columbia

Collaborator:

Cystic Fibrosis Foundation Therapeutics

Information provided by:

University of British Columbia

ClinicalTrials.gov Identifier:

NCT00686361

First received: May 26, 2008

Last updated: June 6, 2011

Last verified: June 2011

 

7.3 Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum Disorders
Sponsor:

Sheba Medical Center

Collaborator:

The Israeli Society of Clinical Pediatrics (HIPAK)

Information provided by (Responsible Party):

Dr. Lidia Gabis MD, Sheba Medical Center

ClinicalTrials.gov Identifier:

NCT01098383

First received: March 11, 2010

Last updated: July 17, 2014

Last verified: July 2014